A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
Status:
Active, not recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of drugs as a possible treatment for metastatic
breast cancer.
The interventions involved in this study are:
- Pembrolizumab
- Trastuzumab emtansine (also called T-DM1)